Buchumschlag

Host-specific functional evolution of seal influenza A virus NS1 protein following avian-to-seal transmission.

Fuente: PubMed

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Kuryshko, Maryna, Luttermann, Christine, Bayoumi, Mahmoud, Mostafa, Ahmed, Weißmann, Jula, Schäfer, Alexander, Wendt, Lisa, Hoenen, Thomas, Müller, Jendrik, Martinez-Sobrido, Luis, Mettenleiter, Thomas C, Abdelwhab, Elsayed M
Format:	Artículo científico
Sprache:	en
Veröffentlicht:	Journal of virology 2026
Schlagworte:	Viral Nonstructural Proteins Animals Influenza A virus Humans Birds Host Specificity Influenza in Birds Phylogeny Orthomyxoviridae Infections Evolution, Molecular Virus Replication Influenza, Human Amino Acid Substitution Interferons
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Highly pathogenic avian influenza virus (H5N5) detected in an Atlantic walrus () in the Svalbard Archipelago, Norway, 2023.
von: Postel, Alexander, et al.
Veröffentlicht: (2025)

Unexpected Delayed Incursion of Highly Pathogenic Avian Influenza H5N1 (Clade 2.3.4.4b) Into the Antarctic Region.
von: Lisovski, Simeon, et al.
Veröffentlicht: (2024)

Genomic analysis of high pathogenicity avian influenza viruses from Antarctica reveals multiple introductions from South America.
von: Ogrzewalska, Maria, et al.
Veröffentlicht: (2026)

Genetic Diversity of Highly Pathogenic Avian Influenza Viruses Isolated in Hokkaido, Japan, During Winter 2024-2025.
von: Isoda, Norikazu, et al.
Veröffentlicht: (2025)

No evidence of influenza A virus infection in marine mammals stranded in Basque Country coast (Northern Spain) in the context of H5N1 clade 2.3.4.4b expansion.
von: López-Morales, Ane, et al.
Veröffentlicht: (2026)

Detection of Two High Pathogenicity Avian Influenza Virus (HPAIV) Subtypes, H5N1 and H5N5, in a Mass Mortality Event in Wild Seabirds and Co-Location With Dead Seals.
von: Falchieri, Marco, et al.
Veröffentlicht: (2026)

Nurses’ knowledge about safety in the clinical management of patients with influenza: a cross-sectional study
von: Regina Kelly Guimarães Gomes Campos
Veröffentlicht: (2025)

A Novel Coupled Epistatic Algorithm to Predict Host-Adapted Hidden Genotypes of Influenza A Virus Hemagglutinin
von: Jiang, Shu-Yang, et al.
Veröffentlicht: (2026)

Influenza vaccination in Brazil: rationale and caveats
von: Sérgio Souza da Cunha
Veröffentlicht: (2005)

Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID‐19, avian influenza, and MERS‐CoV
von: Mona Mahmoud, et al.
Veröffentlicht: (2024)

Detection of clade 2.3.4.4 highly pathogenic avian influenza H5 viruses in healthy wild birds in the Hadeji‐Nguru wetland, Nigeria 2022
von: Kayode Olawuyi, et al.
Veröffentlicht: (2024)

Influenza. Vacunas clásicas y novedosas a las puertas de otra pandemia
von: Raiza Martínez
Veröffentlicht: (2006)

Relação entre morbidade hospitalar e cobertura vacinal contra Influenza A
von: Fernanda Ribeiro Baptista Marques
Veröffentlicht: (2012)

Strain Agnostic Influenza Virus Propagation in a Serum‐Free, Suspension‐Adapted MDCK Cell Line
von: Jessica B. Huskey, et al.
Veröffentlicht: (2026)

Variability in the Timing of Respiratory Syncytial Virus Epidemics in Guatemala, 2008–2018
von: Sarah Hamid, et al.
Veröffentlicht: (2024)

The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023
von: Obadiah Kenji, et al.
Veröffentlicht: (2026)

Route of Inoculation Determines Symptom Profile and Replication Dynamics After low Pathogenic Avian Influenza A(H7N9) Virus Infection in Ferrets
von: Sook‐San Wong, et al.
Veröffentlicht: (2025)

Influenza Vaccine Effectiveness in Australia During 2017–2019
von: Tanya Diefenbach‐Elstob, et al.
Veröffentlicht: (2025)

Postinfection Pig and Ferret Antisera Show Similar Antigenic Profiles for Human Influenza A(H1N1pdm09) Viruses
von: Ruth Harvey, et al.
Veröffentlicht: (2026)

Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2
von: Quentin Richier, et al.
Veröffentlicht: (2024)

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
von: Angela M. C. Rose, et al.
Veröffentlicht: (2024)

Impact of the COVID‐19 related border restrictions on influenza and other common respiratory viral infections in New Zealand
von: Q. Sue Huang, et al.
Veröffentlicht: (2024)

Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania
von: Lydia M. Mendoza, et al.
Veröffentlicht: (2025)

Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice
von: Sijing Yan, et al.
Veröffentlicht: (2025)

Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024
von: Liliana Antunes, et al.
Veröffentlicht: (2025)

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024
von: Lore Merdrignac, et al.
Veröffentlicht: (2024)

Neurologic Complications of Influenza and Potential Protective Vaccine Effects
von: Ann R. Falsey
Veröffentlicht: (2025)

Age‐Related Asymptomatic Rhinovirus Infections Contribute to the Sustained Prevalence in Adults and Are Not Mitigated by Nonpharmaceutical Interventions
von: Dong Wei, et al.
Veröffentlicht: (2026)

Expanded Genomic Surveillance and Seasonal Comparisons of Human Respiratory Syncytial Virus Infections in Minnesota, USA, 2023–2025
von: Daniel Evans, et al.
Veröffentlicht: (2026)

High Infection Risk Among Health Care Workers During the First SARS‐CoV‐2 Wave in Niamey, Niger
von: Hamidou Lazoumar Ramatoulaye, et al.
Veröffentlicht: (2025)

Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study
von: Kristoffer Grundtvig Skaarup, et al.
Veröffentlicht: (2025)

Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh
von: Mohammad Abdul Aleem, et al.
Veröffentlicht: (2024)

Changes in the Epidemiology of Influenza and Respiratory Syncytial Virus During 2020–2022 Relative to the Pre‐COVID‐19 Pandemic Period (2017–2020) From Systematic Sentinel Syndromic Surveillance in South Africa
von: Sibongile Walaza, et al.
Veröffentlicht: (2026)

Longitudinal SARS‐CoV‐2 Antibody Response in Healthcare Workers: Benefit of Prior Infection and Heterologous Boosting on Anti‐Spike IgG Immunity
von: Els Van Nedervelde, et al.
Veröffentlicht: (2026)

Issue Information
Veröffentlicht: (2025)

Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)
von: Ulrike Baum, et al.
Veröffentlicht: (2025)

Burden of Severe Disease Associated With Influenza, SARS‐CoV‐2 and RSV in Spain During the 2024–2025 Winter Season
von: Daniel Aguilar Figueroa, et al.
Veröffentlicht: (2025)

Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain
von: Matilde Zornoza Moreno, et al.
Veröffentlicht: (2024)

Correction to “The Development of Global Genomic Surveillance of Respiratory Syncytial Virus: Insights From 25 Project Countries, 2019–2023”
Veröffentlicht: (2026)

The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
von: Jela Aćimović, et al.
Veröffentlicht: (2025)